An Interview with the Editor-in-Chief of Clinical and Vaccine Immunology
Clinical and Vaccine Immunology has been named a Rising Star of immunology journals in Essiential Science Indicators from Thomson Reuters several times in a row. Science Watch sat down with Dr. Susan Plaeger, the Editor-in-Chief, to discuss how her journal gained the success it enjoys today and where she sees it going in the future.
Though the title Clinical and Vaccine Immunology was introduced in 2006, the publication has existed in the form of Clinical and Diagnostic Laboratory Immunology since 1994. An online publication for the American Society of Microbiology (ASM), it extensively covers all aspects of immunology, including microbiological immunology, veterinarian immunology, and many aspects of vaccine research.
Dr. Plaeger credits expanding the journal’s scope to include vaccine research as a key ingredient to CVI’s success. However, Dr. Plaeger stresses that remaining true to its primary focus played a key role as well. “I believe it also was important to maintain the focus on the area for which we had become known and sought out for publications, i.e., clinical laboratory immunology. Coverage of clinical immunology unrelated to microbes is an area not covered by any other ASM journal and was cited as a need by our members, so we fill a niche there as well.” Her discussion on the importance of both focus and strategic expansion provide food for thought on what the ideal scope of a journal should be.
< • The Forum home